AZ-505

N/A

Report date: 2025/05/15 15:30:44
NME

Base Information

Drug NameAZ-505
Drug Alias NameAZ505AZ-505
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN-lysine methyltransferase SMYD2 inhibitors
TargetsN-lysine methyltransferase SMYD2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A